0
0
0
0
1
2
3
$0
Is Synopsys solid or fragile? The Finex Financial Health Scanner reads SNPS's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2025) | $7.1B |
|---|---|
| Net income | $1.3B |
| Operating margin | 13.0% |
| Net margin | 18.9% |
| Cash and investments | $3.0B |
| Total debt | $13.5B |
| Free cash flow | $3.4B |
| Revenue growth (1 year) | 15.1% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.